Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia

H Jiang, XH Liu, J Kong, J Wang, JS Jia… - Leukemia & …, 2021 - Taylor & Francis
To evaluate the efficacy of interferon-α (IFN-α) as maintenance therapy in patients with
favorable-risk acute myeloid leukemia (AML), this retrospective study enrolled 84 patients …
被引用次数：17 相关文章

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.

H Jiang, XH Liu, J Kong, J Wang, JS Jia… - Leukemia & …, 2021 - europepmc.org
To evaluate the efficacy of interferon-α (IFN-α) as maintenance therapy in patients with
favorable-risk acute myeloid leukemia (AML), this retrospective study enrolled 84 patients …

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia

H Jiang, XH Liu, J Kong, J Wang… - Leukemia & …, 2021 - pubmed.ncbi.nlm.nih.gov
To evaluate the efficacy of interferon-α (IFN-α) as maintenance therapy in patients with
favorable-risk acute myeloid leukemia (AML), this retrospective study enrolled 84 patients …

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.

H Jiang, XH Liu, J Kong, J Wang, JS Jia… - Leukemia & …, 2021 - search.ebscohost.com
To evaluate the efficacy of interferon-α (IFN-α) as maintenance therapy in patients with
favorable-risk acute myeloid leukemia (AML), this retrospective study enrolled 84 patients …